Skip to main content
OpenTrials

Clinical trial condition

Respiratory Tract Infections

Explore clinical trials studying Respiratory Tract Infections. Study availability and eligibility vary by location and protocol.

9,627 public trials 646 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Tract Infections trial results

Completed

VIR-7831 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

NCT05780281

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
Locations
  • Banner University Medical Center Tucson (Site 206-004), 1625 N. Campbell Avenue Tucson, Arizona, United States
  • Southern Arizona VA Healthcare System (Site 074-009), 3601 S. 6th Ave. Tucson, Arizona, United States
  • Community Regional Medical Center (Site 203-005), 2823 Fresno Street Fresno, California, United States
  • VA Loma Linda Healthcare System (Site 074-017), 11201 Benton Street Loma Linda, California, United States
View all 105 locations
View Trial Details
Completed

Multicenter Double Blind, Parallel-group Phase 2/3 Trial, to Study Raloxifene in Adult COVID-19 Patients.

NCT05172050

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
Locations
  • CHU Amiens Amiens, France
  • Clinique de l'infirmerie protestante de Lyon Caluire-et-Cuire, France
  • CH Emile Roux le Puy en Velay Le Puy-en-Velay, France
  • Centre Hospitalier de Troyes Troyes, France
View Trial Details
Completed

Nicotinamide Riboside in SARS-CoV-2 (COVID-19) Patients for Renal Protection

NCT04818216

Conditions
Acute Kidney Injury, COVID-19, Coronaviridae Infections, +18 more
Locations
  • Icahn School of Medicine at Mount Sinai New York, United States
  • The University of Texas Health Science Center at San Antonio San Antonio, Texas, United States
  • University Health Systems San Antonio, Texas, United States
  • Harborview Medical Center Seattle, Washington, United States
View Trial Details
Completed

A Study to Evaluate the Efficacy, Immune Response, and Safety of a COVID-19 Vaccine in Adults ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to<18 Years) at Risk for SARS-CoV-2

NCT04611802

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +12 more
Locations
  • Alabama Clinical Therapeutics, Llc (Pediatric Site) Birmingham, Alabama, United States
  • Accel Research Sites (Adult Site) Birmingham, Alabama, United States
  • Central Research Associates, Inc (Pediatric Site) Birmingham, Alabama, United States
  • The Pain Center of Arizona (Adult Site) Phoenix, Arizona, United States
View all 154 locations
View Trial Details

Related conditions